2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee
- PMID: 36031461
- DOI: 10.1016/j.jacc.2022.07.006
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee
Erratum in
-
Correction.J Am Coll Cardiol. 2023 Jan 3;81(1):104. doi: 10.1016/j.jacc.2022.11.016. J Am Coll Cardiol. 2023. PMID: 36599606 No abstract available.
Keywords: ACC Expert Consensus Decision Pathway; LDL dyslipidemia; PCSK9 inhibitors; bempedoic acid cardiovascular disease; cholesterol; ezetimibe; inclisiran; lipids; statins.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
